245 related articles for article (PubMed ID: 14718261)
21. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
Giuffrida A; Beltramo M; Piomelli D
J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
[TBL] [Abstract][Full Text] [Related]
23. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening.
De Bank PA; Kendall DA; Alexander SP
Biochem Pharmacol; 2005 Apr; 69(8):1187-93. PubMed ID: 15794939
[TBL] [Abstract][Full Text] [Related]
24. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
25. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
De Petrocellis L; Melck D; Ueda N; Maurelli S; Kurahashi Y; Yamamoto S; Marino G; Di Marzo V
Biochem Biophys Res Commun; 1997 Feb; 231(1):82-8. PubMed ID: 9070224
[TBL] [Abstract][Full Text] [Related]
26. Anandamide transport: a critical review.
Glaser ST; Kaczocha M; Deutsch DG
Life Sci; 2005 Aug; 77(14):1584-604. PubMed ID: 15979096
[TBL] [Abstract][Full Text] [Related]
27. Role of FAAH-like anandamide transporter in anandamide inactivation.
Leung K; Elmes MW; Glaser ST; Deutsch DG; Kaczocha M
PLoS One; 2013; 8(11):e79355. PubMed ID: 24223930
[TBL] [Abstract][Full Text] [Related]
28. Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin.
Sandberg A; Fowler CJ
Chem Phys Lipids; 2005 Apr; 134(2):131-9. PubMed ID: 15784231
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin.
Fowler CJ; Tiger G; López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Ramos JA
J Enzyme Inhib Med Chem; 2003 Jun; 18(3):225-31. PubMed ID: 14506913
[TBL] [Abstract][Full Text] [Related]
30. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides.
Quistad GB; Sparks SE; Casida JE
Toxicol Appl Pharmacol; 2001 May; 173(1):48-55. PubMed ID: 11350214
[TBL] [Abstract][Full Text] [Related]
31. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
32. Natural and synthetic endocannabinoids and their structure-activity relationships.
Palmer SL; Khanolkar AD; Makriyannis A
Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
[TBL] [Abstract][Full Text] [Related]
33. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
34. Evidence against the presence of an anandamide transporter.
Glaser ST; Abumrad NA; Fatade F; Kaczocha M; Studholme KM; Deutsch DG
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4269-74. PubMed ID: 12655057
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
[TBL] [Abstract][Full Text] [Related]
36. The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs.
Wahn H; Wolf J; Kram F; Frantz S; Wagner JA
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2491-6. PubMed ID: 16055511
[TBL] [Abstract][Full Text] [Related]
37. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase.
Deutsch DG; Glaser ST; Howell JM; Kunz JS; Puffenbarger RA; Hillard CJ; Abumrad N
J Biol Chem; 2001 Mar; 276(10):6967-73. PubMed ID: 11118429
[TBL] [Abstract][Full Text] [Related]
38. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
39. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
40. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.
Thors L; Alajakku K; Fowler CJ
Br J Pharmacol; 2007 Apr; 150(7):951-60. PubMed ID: 17325653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
